FDA Grants Profounda Inc. Orphan Drug Designation for treatment of Granulomatous Amebic Encephalitis
- GAE is a serious infection of the brain and spinal cord that typically occurs in persons with a compromised immune system. - Few...
top of page
Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO
bottom of page